COVID-19 Challenges and Scale-up in Access to Community-Based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine - Zahedul Islam

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Dynamics and Peculiarities of AIDS Mortality in Minsk, Belarus - Shylava, Marharyta

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

SARS-CoV-2 Antibody Seroprevalence in Previously Undiagnosed Persons in Tbilisi, Georgia: Results of Three Repeated Serosurveys - Akaki Abutidze

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

HIV & COVID-19 Coinfection - Anca Streinu-Cercel, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

HIV Prevention in High Risk Populations: Unique Challenges and Solutions - Jean-Michel Molina, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Long-Acting Therapy for PrEP: How Will We Use it? - Luis Mendão

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Rollout of PrEP in Europe: Success Stories and Challenges - Teymur Noori, MSc

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Update on the Use of Generic Drugs for HIV in Europe - Liudmyla Maistat

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

EASL Guidelines on Viral Hepatitis Elimination - Mojca Matičič, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

The Georgian Model for Hepatitis C Elimination (With Reflection on the Impact of COVID-19 Pandemic) - Tengiz Tsertsvadze, MD, PHD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

A Report on The Progress Towards Ending HIV - Nicole Seguy, MD, MPH

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021